Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.

Agoni, Lorenzo; Basu, Indranil; Gupta, Seema; Alfieri, Alan; Gambino, Angela; Goldberg, Gary L; Reddy, E Premkumar; Guha, Chandan.
Int J Radiat Oncol Biol Phys; 88(5): 1180-7, 2014 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-24529717